Objective: Our aim was to validate the previously published claim of a positive relationship between low blood hemoglobin level (anemia) and pulmonary embolism (PE). Methods: This was a retrospective study of patients undergoing cross-sectional imaging to evaluate for PE at an academic medical center. Patients were identified using billing records for charges attributed to either magnetic resonance angiography or computed tomography angiography of the chest from 2008 to 2013. The main outcome measure was mean hemoglobin levels among those with and without PE. Our reference standard for PE status included index imaging results and a 6-month clinical follow-up for the presence of interval venous thromboembolism, conducted via review of the electronic medical record. Secondarily, we performed a subgroup analysis of only those patients who were seen in the emergency department. Finally, we again compared mean hemoglobin levels when limiting our control population to an age-and sex-matched cohort of the included cases. Results: There were 1294 potentially eligible patients identified, of whom 121 were excluded. Of the remaining 1173 patients, 921 had hemoglobin levels analyzed within 24 hours of their index scan and thus were included in the main analysis. Of those 921 patients, 107 (11.6%; 107/921) were positive for PE. We found no significant difference in mean hemoglobin level between those with and without PE regardless of the control group used (12.4 ± 2.1 g/dL and 12.3 ± 2.0 g/dL [P = .85], respectively). Conclusions: Our data demonstrated no relationship between anemia and PE.
Introduction
Pulmonary embolism (PE) is a relatively common pathology; in conjunction with deep vein thrombosis, venous thromboembolism affects between 1 and 2 per 1000 people each year in the United States [1, 2] . Estimates suggest that about 1% of all patients admitted to hospitals die of acute PE and that 10% of all in-hospital deaths are PE related [3] . In a multidecade community-based report of the epidemiology of PE, 30-day mortality from acute PE was 13.3% [4] . Because the diagnosis of PE is challenging due to its nonspecific symptoms and signs (ie, shortness of breath, chest pain, coughing, tachycardia, etc [5] ), many researchers have attempted to develop rational approaches to the evaluation of patients with possible PE. Clinical decision instruments, like the Wells [6] and Revised Geneva Scores [7] , allow physicians to stratify patients with suspected PE into decision-making algorithms. Pretest probability and clinical algorithms guide the patient's subsequent workup, generally involving D-dimer testing and computed tomography angiography (CTA) or magnetic resonance angiography (MRA) of the chest [5, 6] .
Recently, an association between anemia and PE has been reported. In their retrospective study, Can et al [8] found that patients with PE had significantly lower mean hemoglobin levels than sex-and age-matched controls. They proposed that this was due to decreased secretion of antithrombotic mediators, initiated by low blood viscosity in anemic states, resulting in increased clotting [8] . If validated, this finding could be of significant importance because the identification of a new risk factor for PE has the potential to direct further research and improve upon the performance of existing clinical decision instruments. Furthermore, previous literature has identified a trend of increased mortality in patients who are anemic [9] .
Although hemoglobin level testing is not currently a component of any validated clinical decision instrument for PE, a complete blood count is often drawn in the workup of suspected PE because of the potential for other alternative diagnoses, like pneumonia [10] . Indeed, 
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American Journal of Emergency Medicine j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / a j e m 35% of all patients in US emergency departments (EDs), regardless of chief concern, have complete blood counts analyzed [11] . The integration of this test into updated clinical decision instruments for PE, therefore, would be relatively simple. The intent of this study is to validate the findings of Can et al-that anemia has a positive association with the diagnosis of PE-using a control population of those evaluated for PE but with a negative diagnostic workup. Although Can and colleagues supplied a plausible argument for why anemia would contribute to developing PE, we hypothesized that there would be no difference in hemoglobin levels between those with and without PE.
Methods

Study design
This is a retrospective case-control study of patients who underwent cross-sectional imaging for the evaluation of PE between April 1, 2008, and March 31, 2013, at our academic medical center in the Midwestern United States. This cohort of patients represents a subset of a parent study that compared patient outcomes for those undergoing pulmonary CTA vs MRA for the evaluation of PE. In the parent study, the general prevalence of venous thromboembolism for patients evaluated in the ED was 8.9% (41/459). The study was Health Insurance Portability and Accountability Act-compliant and approved by our university's institutional review board.
Patient selection
All patients who underwent pulmonary MRA for the diagnosis of PE during the study period were identified using billing information. Next, we selected another group comprised of a random sample of patients who were age-and sex-matched to the MRA group but had undergone pulmonary CTA instead of MRA during the study period using the same billing database. The combination of these 2 groups established our research cohort. Patients were only included in the study once; if a patient had multiple imaging tests performed during the study period to evaluate for PE, only the first encounter was used. Patients were excluded for pregnancy, concomitant acute atrial fibrillation, indwelling inferior vena cava filter, anticoagulant use for N30 days prior to index scan, or absence of a hemoglobin level analyzed in the 24 hours prior to the index scan.
Data collection
We used Research Electronic Data Capture (REDCap [12] ) to develop a data abstraction instrument, which our abstractors used in conjunction with a standardized data abstraction protocol. This protocol made use of a search function embedded within our electronic health record, which returned notes that included specific search terms (eg, PE, venous thromboembolism, bleeding) as well as synonyms as defined by a robust medical dictionary provided by the electronic health record vendor (Epic Systems, Verona, WI). Using the original data abstraction protocol, the primary data abstractor (a full-time research specialist) trained on the first 80 cases, after which point the protocol was refined to address data abstraction uncertainties. The training cases were then reevaluated, and the primary abstractor trained 2 additional data abstractors (both research nurses) to use the protocol and REDCap. For subsequent uncertain outcomes, cases were flagged for review by an expert panel of 3 investigators including 2 radiologists and an emergency physician. The final results were adjudicated according to consensus opinion.
Outcomes and analysis
Our primary outcome was mean hemoglobin level among patients with versus those without PE. Negative and nondiagnostic imaging test results, which we defined as those marked "equivocal," were considered negative for PE unless a PE or deep vein thrombosis was diagnosed within 6 months of the index visit on medical record review. This caveat was included to account for falsely negative index imaging test results. Conversely, all positive imaging test results at the index visit were considered positive for PE. Secondary analyses included a comparison of hemoglobin levels when the study population was limited to only those patients evaluated in the ED as well as a comparison of hemoglobin levels between those with PE and a randomly selected subset of controls that were matched to cases by age (±2 years) and sex. Results are presented as mean values with standard deviations. Statistical significance was evaluated using a Student t test, with a threshold of P b .05 for statistical significance. All calculations were performed using GraphPad Quick Calcs (GraphPad Software, La Jolla, CA) [13] .
Results
Patient characteristics
Overall, 1294 potentially eligible patients were identified during the study period. Of those, 121 were excluded; 87 were anticoagulated, 27 were in atrial fibrillation, 18 had an inferior vena cava filter, and 8 were pregnant (some patients met multiple exclusionary criteria). An additional 252 did not have a hemoglobin result documented in their medical record in the 24 hours prior to their index imaging test. The remaining 921 constituted the research cohort. Among these, 107 patients had PE (11.6%) and served as cases, whereas the remaining 814 patients served as controls. In the control group, 652 patients were female (80.1%), and the average age was 38.9 ± 16.5 years. In the case group (PE positive), 73 patients were female (68.2%), and the average age was 43.8 ± 19.0 years. Baseline characteristics of the case and control populations are displayed in Table. Patient flow through the study and results are presented in Figure. 
Main results
Mean hemoglobin levels were not different between those with vs those without PE. Hemoglobin levels were 12.4 ± 2.1 g/dL and 12.3 ± 2.0 g/dL (P = .85), respectively.
Secondary results
When limited to the 607 patients who were evaluated in the ED, there was no significant difference in mean hemoglobin levels among those with PE compared with those without PE; hemoglobin levels remained comparable at 12.8 ± 2.0 g/dL and 12.9 ± 1.7 g/dL (P = .66). When our control group was limited to a randomly generated cohort of patients who were age-and sex-matched to cases, hemoglobin levels were 12.4 ± 2.1 g/dL and 12.4 ± 1.8 g/dL (P = 1.0), respectively.
Discussion
The goal of this study was to assess a previously reported positive correlation between anemia and the diagnosis of PE. We found no evidence to support this reported relationship. Mean hemoglobin levels were comparable among patients with and without PE throughout the main analysis and the 2 subanalyses we conducted.
Very limited research exists investigating the association of anemia and PE, save for a single case report regarding autoimmune hemolytic anemia and subsequent PE shortly after this diagnosis [14] . A fundamental distinction between the study of Can et al and ours was the inclusion criteria. Because all patients in our study were of high enough risk to warrant cross-sectional imaging (CTA or MRA) to evaluate for PE, we enrolled a more uniform risk profile of patients. In the previous study, controls for PE cases were selected based on their proximity of arrival time to the ED, sex, and age. As such, 162 153 patients presented to their ED during the 2 study years and only 212 had PE (0.13%). Of the 402 patient case-control cohort, the average age was 63 ± 17 years, and both case and control groups had an even sex divide. This contrasts with our study cohort, which had an average age of 44 ± 19 years and high proportion of women, comprising 68% of our cases as well as 80% of controls.
Although this difference in age and sex may partially explain the difference in study outcomes, it is important to note that the basis of selection for the study of Can et al neglected to account for suspicion of PE.
Patients with PE present to the ED with varying symptoms like chest pain, exercise intolerance, and shortness of breath. Generally, these chief concerns are associated with more serious pathologies than those of the general ED population. Because of this, the control group in Can et al may have been, on average, a healthier cohort than their case group. It is possible that patients who are suspected of having PE are a population with higher mortality and morbidity than the general ED population and, by extension, a population with a higher frequency and/or greater degree of anemia. This critical difference likely contributed to our study findings: no correlation between anemia and PE.
Although we feel that our case-control study was generally well designed, it has limitations. First, not every patient suspected of PE had a hemoglobin level in our electronic health record, which could have led to information bias. Although we do not have data to explain why these patients did not have a level drawn, it seems plausible that these patients may have been referred from another hospital or clinic where the test was performed. Notably, our overall mean hemoglobin level for both cases and controls was similar to the population reported by Can et al. A second limitation was the selection method for our research cohort. Because we first identified all patients who underwent pulmonary MRA for the diagnosis of PE and our physicians preferentially order this test on young women to spare them the radiation exposure of pulmonary CTA, our overall cohort had a significantly higher proportion of young women than the general population of patients undergoing evaluation of possible PE [15] . This selection difference could have masked a possible relationship between PE and anemia in older and male patients. Finally, the determination of PE status when imaging results were negative was reliant on electronic health record notes to verify the absence of PE. It is possible that patients had a falsely negative index imaging test results but no subsequent notes within the electronic health record that identified the missed PE.
In conclusion, we found no relationship between anemia and the presence of PE or the interval development of venous thromboembolism at 6 months after undergoing cross-sectional imaging for the diagnosis of PE. We respectfully suggest that the correlation reported by Can and colleagues was spurious. Data are reported as means or proportions with associated confidence intervals as well as associated P values testing for differences between groups. DVT = deep vein thrombosis.
Figure.
Patient flow and results. Schematic representation of patient movement through the study steps as well as primary and secondary results. Hemoglobin levels are reported in grams per deciliter.
